サンプル依頼リスト カート
  • English
デフォルト表紙
市場調査レポート
商品コード
1288136

世界の網膜変性疾患治療薬市場：考察と予測 (2029年まで)

Global Retinal Degenerative Disease Treatment Drugs Market Insights, Forecast to 2029
出版日: | 発行: QYResearch | ページ情報: 英文 112 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
世界の網膜変性疾患治療薬市場：考察と予測 (2029年まで)
出版日: 2023年06月09日
発行: QYResearch
ページ情報: 英文 112 Pages
納期: 2～3営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

当レポートは、網膜変性疾患治療薬 (Retinal Degenerative Disease Treatment Drugs) 市場について調査しており、市場規模や動向・需要の予測、成長要因および課題の分析、タイプ・用途・企業・地域別の内訳、競合情勢、主要企業のプロファイルなどの情報を提供しています。

目次

第1章 調査対象

  • 網膜変性疾患治療薬の製品概要
  • 市場：タイプ別
    • 世界の網膜変性疾患治療薬の市場規模成長率：タイプ別, 2018 VS 2022 VS 2029
    • Age Related Macular Degeneration (AMD) Treatment Drug
    • Retinitis Pigmentosa (RP) Treatment Drug
  • 市場：用途別
    • 世界の網膜変性疾患治療薬の市場規模成長率：用途別, 2018 VS 2022 VS 2029
    • Hospital
    • Clinic
    • Others
  • 前提条件と制限
  • 調査目的
  • 対象期間

第2章 レポート概要

  • 世界の網膜変性疾患治療薬売上予測・予想 2018-2029
  • 世界の網膜変性疾患治療薬の収益：地域別
    • 世界の網膜変性疾患治療薬の収益：地域別: 2018 VS 2022 VS 2029
    • 世界の網膜変性疾患治療薬の収益：地域別 (2018-2023)
    • 世界の網膜変性疾患治療薬の収益：地域別 (2024-2029)
    • 世界の網膜変性疾患治療薬の収益市場シェア 地域別 (2018-2029)
  • 世界の網膜変性疾患治療薬売上予測・予想 2018-2029
  • 世界の網膜変性疾患治療薬の販売：地域別
    • 世界の網膜変性疾患治療薬の販売：地域別: 2018 VS 2022 VS 2029
    • 世界の網膜変性疾患治療薬の販売：地域別 (2018-2023)
    • 世界の網膜変性疾患治療薬の販売：地域別 (2024-2029)
    • 世界の網膜変性疾患治療薬の販売市場シェア 地域別 (2018-2029)
  • US & カナダ
  • 欧州
  • 中国
  • アジア（中国を除く）
  • 中東, アフリカ ・ラテンアメリカ

第3章 競合：企業別

  • 世界の網膜変性疾患治療薬の販売：企業別
    • 世界の網膜変性疾患治療薬の販売：企業別 (2018-2023)
    • 世界の網膜変性疾患治療薬の販売市場シェア：企業別 (2018-2023)
    • 世界の上位10・上位5企業： 網膜変性疾患治療薬 in 2022
  • 世界の網膜変性疾患治療薬の収益：企業別
    • 世界の網膜変性疾患治療薬の収益：企業別 (2018-2023)
    • 世界の網膜変性疾患治療薬の収益市場シェア：企業別 (2018-2023)
    • 世界の上位10・上位5企業： 網膜変性疾患治療薬の収益 2022
  • 世界の主要企業 網膜変性疾患治療薬, 業界ランキング, 2021 VS 2022 VS 2023
  • 世界の網膜変性疾患治療薬の販売価格：企業別
  • 競合情勢の分析
    • 企業の市場集中度 (CR5 and HHI)
    • 世界の網膜変性疾患治療薬の市場シェア：企業タイプ別 (Tier 1, Tier 2, and Tier 3)
  • 世界の主要メーカー 網膜変性疾患治療薬, 製造拠点分布と本社
  • 世界の主要メーカー 網膜変性疾患治療薬, 提供製品と用途
  • 世界の主要メーカー 網膜変性疾患治療薬, 業界参入時期
  • M&A, 拡張計画

第4章 市場規模：タイプ別

  • 世界の網膜変性疾患治療薬の販売：タイプ別
    • 世界の網膜変性疾患治療薬の販売実績：タイプ別 (2018-2023)
    • 世界の網膜変性疾患治療薬の販売予測：タイプ別 (2024-2029)
    • 世界の網膜変性疾患治療薬の販売市場シェア：タイプ別 (2018-2029)
  • 世界の網膜変性疾患治療薬 収益：タイプ別
    • 世界の網膜変性疾患治療薬の収益実績：タイプ別 (2018-2023)
    • 世界の網膜変性疾患治療薬の収益予測：タイプ別 (2024-2029)
    • 世界の網膜変性疾患治療薬の収益市場シェア：タイプ別 (2018-2029)
  • 世界の網膜変性疾患治療薬の価格：タイプ別
    • 世界の網膜変性疾患治療薬の価格：タイプ別 (2018-2023)
    • 世界の網膜変性疾患治療薬の価格予測：タイプ別 (2024-2029)

第5章 市場規模：用途別

  • 世界の網膜変性疾患治療薬の販売：用途別
    • 世界の網膜変性疾患治療薬の販売実績：用途別 (2018-2023)
    • 世界の網膜変性疾患治療薬の販売予測：用途別 (2024-2029)
    • 世界の網膜変性疾患治療薬の販売市場シェア：用途別 (2018-2029)
  • 世界の網膜変性疾患治療薬の収益：用途別
    • 世界の網膜変性疾患治療薬の収益実績：用途別 (2018-2023)
    • 世界の網膜変性疾患治療薬の収益予測：用途別 (2024-2029)
    • 世界の網膜変性疾患治療薬の収益市場シェア：用途別 (2018-2029)
  • 世界の網膜変性疾患治療薬の価格：用途別
    • 世界の網膜変性疾患治療薬の価格：用途別 (2018-2023)
    • 世界の網膜変性疾患治療薬の価格予測：用途別 (2024-2029)

第6章 US & カナダ

  • US & カナダ 網膜変性疾患治療薬 市場規模：タイプ別
    • US & カナダ 網膜変性疾患治療薬の販売：タイプ別 (2018-2029)
    • US & カナダ 網膜変性疾患治療薬 収益：タイプ別 (2018-2029)
  • US & カナダ 網膜変性疾患治療薬 市場規模：用途別
    • US & カナダ 網膜変性疾患治療薬の販売：用途別 (2018-2029)
    • US & カナダ 網膜変性疾患治療薬の収益：用途別 (2018-2029)
  • US & カナダ 網膜変性疾患治療薬 市場規模：国別
    • US & カナダ 網膜変性疾患治療薬の収益：国別: 2018 VS 2022 VS 2029
    • US & カナダ 網膜変性疾患治療薬の販売：国別 (2018-2029)
    • US & カナダ 網膜変性疾患治療薬の収益：国別 (2018-2029)
    • US
    • カナダ

第7章 欧州

  • 欧州の網膜変性疾患治療薬 市場規模：タイプ別
    • 欧州の網膜変性疾患治療薬の販売：タイプ別 (2018-2029)
    • 欧州の網膜変性疾患治療薬 収益：タイプ別 (2018-2029)
  • 欧州の網膜変性疾患治療薬 市場規模：用途別
    • 欧州の網膜変性疾患治療薬の販売：用途別 (2018-2029)
    • 欧州の網膜変性疾患治療薬の収益：用途別 (2018-2029)
  • 欧州の網膜変性疾患治療薬 市場規模：国別
    • 欧州の網膜変性疾患治療薬の収益：国別: 2018 VS 2022 VS 2029
    • 欧州の網膜変性疾患治療薬の販売：国別 (2018-2029)
    • 欧州の網膜変性疾患治療薬の収益：国別 (2018-2029)
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • ロシア

第8章 中国

  • 中国の網膜変性疾患治療薬 市場規模
    • 中国の網膜変性疾患治療薬 売上 (2018-2029)
    • 中国の網膜変性疾患治療薬 収益 (2018-2029)
  • 中国の網膜変性疾患治療薬 市場規模：用途別
    • 中国の網膜変性疾患治療薬の販売：用途別 (2018-2029)
    • 中国の網膜変性疾患治療薬の収益：用途別 (2018-2029)

第9章 アジア（中国を除く）

  • アジア地域 網膜変性疾患治療薬 市場規模：タイプ別
    • アジア地域 網膜変性疾患治療薬の販売：タイプ別 (2018-2029)
    • アジア地域 網膜変性疾患治療薬 収益：タイプ別 (2018-2029)
  • アジア地域 網膜変性疾患治療薬 市場規模：用途別
    • アジア地域 網膜変性疾患治療薬の販売：用途別 (2018-2029)
    • アジア地域 網膜変性疾患治療薬の収益：用途別 (2018-2029)
  • アジア地域 網膜変性疾患治療薬の販売：地域別
    • アジア地域 網膜変性疾患治療薬の収益：地域別: 2018 VS 2022 VS 2029
    • アジア地域 網膜変性疾患治療薬の収益：地域別 (2018-2029)
    • アジア地域 網膜変性疾患治療薬の販売：地域別 (2018-2029)
    • 日本
    • 韓国
    • 台湾
    • 東南アジア
    • インド

第10章 中東, アフリカ ・ラテンアメリカ

  • 中東, アフリカ ・ラテンアメリカの網膜変性疾患治療薬 市場規模：タイプ別
    • 中東, アフリカ ・ラテンアメリカの網膜変性疾患治療薬の販売：タイプ別 (2018-2029)
    • 中東, アフリカ ・ラテンアメリカの網膜変性疾患治療薬 収益：タイプ別 (2018-2029)
  • 中東, アフリカ ・ラテンアメリカの網膜変性疾患治療薬 市場規模：用途別
    • 中東, アフリカ ・ラテンアメリカの網膜変性疾患治療薬の販売：用途別 (2018-2029)
    • 中東, アフリカ ・ラテンアメリカの網膜変性疾患治療薬の収益：用途別 (2018-2029)
  • 中東, アフリカ ・ラテンアメリカの網膜変性疾患治療薬の販売：国別
    • 中東, アフリカ ・ラテンアメリカの網膜変性疾患治療薬の収益：国別: 2018 VS 2022 VS 2029
    • 中東, アフリカ ・ラテンアメリカの網膜変性疾患治療薬の収益：国別 (2018-2029)
    • 中東, アフリカ ・ラテンアメリカの網膜変性疾患治療薬の販売：国別 (2018-2029)
    • ブラジル
    • メキシコ
    • トルコ
    • イスラエル
    • 湾岸協力理事会諸国

第11章 企業プロファイル

  • Regeneron Pharmaceuticals
  • Bayer HealthCare
  • Novartis
  • Roche
  • Kanghong Pharma
  • Merck
  • Takeda
  • Valeant Pharmaceuticals International, Inc
  • Oxurion(ThromboGenics)
  • Santen Pharmaceutical
  • jCyte, Inc.
  • Kodiak Sciences
  • Coherus BioSciences, Inc

第12章 業界チェーンと販売チャネルの分析

  • 網膜変性疾患治療薬 業界チェーン分析
  • 網膜変性疾患治療薬 主要原材料
    • 主要原材料
    • 原材料の主要サプライヤー
  • 網膜変性疾患治療薬 生産形態とプロセス
  • 網膜変性疾患治療薬 販売およびマーケティング
    • 網膜変性疾患治療薬 販売チャネル
    • 網膜変性疾患治療薬 卸業者
  • 網膜変性疾患治療薬 顧客

第13章 市場動向

  • 網膜変性疾患治療薬 業界動向
  • 網膜変性疾患治療薬 市場の促進要因
  • 網膜変性疾患治療薬 市場の課題
  • 網膜変性疾患治療薬 市場の抑制要因

第14章 主な調査結果 世界の網膜変性疾患治療薬の主な市場調査結果

第15章 付録

図表

List of Tables

  • Table 1. Global Retinal Degenerative Disease Treatment Drugs Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
  • Table 2. Major Manufacturers of Age Related Macular Degeneration (AMD) Treatment Drug
  • Table 3. Major Manufacturers of Retinitis Pigmentosa (RP) Treatment Drug
  • Table 4. Global Retinal Degenerative Disease Treatment Drugs Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
  • Table 5. Global Retinal Degenerative Disease Treatment Drugs Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
  • Table 6. Global Retinal Degenerative Disease Treatment Drugs Revenue by Region (2018-2023) & (US$ Million)
  • Table 7. Global Retinal Degenerative Disease Treatment Drugs Revenue by Region (2024-2029) & (US$ Million)
  • Table 8. Global Retinal Degenerative Disease Treatment Drugs Revenue Market Share by Region (2018-2023)
  • Table 9. Global Retinal Degenerative Disease Treatment Drugs Revenue Market Share by Region (2024-2029)
  • Table 10. Global Retinal Degenerative Disease Treatment Drugs Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
  • Table 11. Global Retinal Degenerative Disease Treatment Drugs Sales by Region (2018-2023) & (K Units)
  • Table 12. Global Retinal Degenerative Disease Treatment Drugs Sales by Region (2024-2029) & (K Units)
  • Table 13. Global Retinal Degenerative Disease Treatment Drugs Sales Market Share by Region (2018-2023)
  • Table 14. Global Retinal Degenerative Disease Treatment Drugs Sales Market Share by Region (2024-2029)
  • Table 15. Global Retinal Degenerative Disease Treatment Drugs Sales by Manufacturers (2018-2023) & (K Units)
  • Table 16. Global Retinal Degenerative Disease Treatment Drugs Sales Share by Manufacturers (2018-2023)
  • Table 17. Global Retinal Degenerative Disease Treatment Drugs Revenue by Manufacturers (2018-2023) & (US$ Million)
  • Table 18. Global Retinal Degenerative Disease Treatment Drugs Revenue Share by Manufacturers (2018-2023)
  • Table 19. Global Key Players of Retinal Degenerative Disease Treatment Drugs, Industry Ranking, 2021 VS 2022 VS 2023
  • Table 20. Retinal Degenerative Disease Treatment Drugs Price by Manufacturers 2018-2023 (US$/Unit)
  • Table 21. Global Retinal Degenerative Disease Treatment Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
  • Table 22. Global Retinal Degenerative Disease Treatment Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Retinal Degenerative Disease Treatment Drugs as of 2022)
  • Table 23. Global Key Manufacturers of Retinal Degenerative Disease Treatment Drugs, Manufacturing Base Distribution and Headquarters
  • Table 24. Global Key Manufacturers of Retinal Degenerative Disease Treatment Drugs, Product Offered and Application
  • Table 25. Global Key Manufacturers of Retinal Degenerative Disease Treatment Drugs, Date of Enter into This Industry
  • Table 26. Mergers & Acquisitions, Expansion Plans
  • Table 27. Global Retinal Degenerative Disease Treatment Drugs Sales by Type (2018-2023) & (K Units)
  • Table 28. Global Retinal Degenerative Disease Treatment Drugs Sales by Type (2024-2029) & (K Units)
  • Table 29. Global Retinal Degenerative Disease Treatment Drugs Sales Share by Type (2018-2023)
  • Table 30. Global Retinal Degenerative Disease Treatment Drugs Sales Share by Type (2024-2029)
  • Table 31. Global Retinal Degenerative Disease Treatment Drugs Revenue by Type (2018-2023) & (US$ Million)
  • Table 32. Global Retinal Degenerative Disease Treatment Drugs Revenue by Type (2024-2029) & (US$ Million)
  • Table 33. Global Retinal Degenerative Disease Treatment Drugs Revenue Share by Type (2018-2023)
  • Table 34. Global Retinal Degenerative Disease Treatment Drugs Revenue Share by Type (2024-2029)
  • Table 35. Retinal Degenerative Disease Treatment Drugs Price by Type (2018-2023) & (US$/Unit)
  • Table 36. Global Retinal Degenerative Disease Treatment Drugs Price Forecast by Type (2024-2029) & (US$/Unit)
  • Table 37. Global Retinal Degenerative Disease Treatment Drugs Sales by Application (2018-2023) & (K Units)
  • Table 38. Global Retinal Degenerative Disease Treatment Drugs Sales by Application (2024-2029) & (K Units)
  • Table 39. Global Retinal Degenerative Disease Treatment Drugs Sales Share by Application (2018-2023)
  • Table 40. Global Retinal Degenerative Disease Treatment Drugs Sales Share by Application (2024-2029)
  • Table 41. Global Retinal Degenerative Disease Treatment Drugs Revenue by Application (2018-2023) & (US$ Million)
  • Table 42. Global Retinal Degenerative Disease Treatment Drugs Revenue by Application (2024-2029) & (US$ Million)
  • Table 43. Global Retinal Degenerative Disease Treatment Drugs Revenue Share by Application (2018-2023)
  • Table 44. Global Retinal Degenerative Disease Treatment Drugs Revenue Share by Application (2024-2029)
  • Table 45. Retinal Degenerative Disease Treatment Drugs Price by Application (2018-2023) & (US$/Unit)
  • Table 46. Global Retinal Degenerative Disease Treatment Drugs Price Forecast by Application (2024-2029) & (US$/Unit)
  • Table 47. US & Canada Retinal Degenerative Disease Treatment Drugs Sales by Type (2018-2023) & (K Units)
  • Table 48. US & Canada Retinal Degenerative Disease Treatment Drugs Sales by Type (2024-2029) & (K Units)
  • Table 49. US & Canada Retinal Degenerative Disease Treatment Drugs Revenue by Type (2018-2023) & (US$ Million)
  • Table 50. US & Canada Retinal Degenerative Disease Treatment Drugs Revenue by Type (2024-2029) & (US$ Million)
  • Table 51. US & Canada Retinal Degenerative Disease Treatment Drugs Sales by Application (2018-2023) & (K Units)
  • Table 52. US & Canada Retinal Degenerative Disease Treatment Drugs Sales by Application (2024-2029) & (K Units)
  • Table 53. US & Canada Retinal Degenerative Disease Treatment Drugs Revenue by Application (2018-2023) & (US$ Million)
  • Table 54. US & Canada Retinal Degenerative Disease Treatment Drugs Revenue by Application (2024-2029) & (US$ Million)
  • Table 55. US & Canada Retinal Degenerative Disease Treatment Drugs Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
  • Table 56. US & Canada Retinal Degenerative Disease Treatment Drugs Revenue by Country (2018-2023) & (US$ Million)
  • Table 57. US & Canada Retinal Degenerative Disease Treatment Drugs Revenue by Country (2024-2029) & (US$ Million)
  • Table 58. US & Canada Retinal Degenerative Disease Treatment Drugs Sales by Country (2018-2023) & (K Units)
  • Table 59. US & Canada Retinal Degenerative Disease Treatment Drugs Sales by Country (2024-2029) & (K Units)
  • Table 60. Europe Retinal Degenerative Disease Treatment Drugs Sales by Type (2018-2023) & (K Units)
  • Table 61. Europe Retinal Degenerative Disease Treatment Drugs Sales by Type (2024-2029) & (K Units)
  • Table 62. Europe Retinal Degenerative Disease Treatment Drugs Revenue by Type (2018-2023) & (US$ Million)
  • Table 63. Europe Retinal Degenerative Disease Treatment Drugs Revenue by Type (2024-2029) & (US$ Million)
  • Table 64. Europe Retinal Degenerative Disease Treatment Drugs Sales by Application (2018-2023) & (K Units)
  • Table 65. Europe Retinal Degenerative Disease Treatment Drugs Sales by Application (2024-2029) & (K Units)
  • Table 66. Europe Retinal Degenerative Disease Treatment Drugs Revenue by Application (2018-2023) & (US$ Million)
  • Table 67. Europe Retinal Degenerative Disease Treatment Drugs Revenue by Application (2024-2029) & (US$ Million)
  • Table 68. Europe Retinal Degenerative Disease Treatment Drugs Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
  • Table 69. Europe Retinal Degenerative Disease Treatment Drugs Revenue by Country (2018-2023) & (US$ Million)
  • Table 70. Europe Retinal Degenerative Disease Treatment Drugs Revenue by Country (2024-2029) & (US$ Million)
  • Table 71. Europe Retinal Degenerative Disease Treatment Drugs Sales by Country (2018-2023) & (K Units)
  • Table 72. Europe Retinal Degenerative Disease Treatment Drugs Sales by Country (2024-2029) & (K Units)
  • Table 73. China Retinal Degenerative Disease Treatment Drugs Sales by Type (2018-2023) & (K Units)
  • Table 74. China Retinal Degenerative Disease Treatment Drugs Sales by Type (2024-2029) & (K Units)
  • Table 75. China Retinal Degenerative Disease Treatment Drugs Revenue by Type (2018-2023) & (US$ Million)
  • Table 76. China Retinal Degenerative Disease Treatment Drugs Revenue by Type (2024-2029) & (US$ Million)
  • Table 77. China Retinal Degenerative Disease Treatment Drugs Sales by Application (2018-2023) & (K Units)
  • Table 78. China Retinal Degenerative Disease Treatment Drugs Sales by Application (2024-2029) & (K Units)
  • Table 79. China Retinal Degenerative Disease Treatment Drugs Revenue by Application (2018-2023) & (US$ Million)
  • Table 80. China Retinal Degenerative Disease Treatment Drugs Revenue by Application (2024-2029) & (US$ Million)
  • Table 81. Asia Retinal Degenerative Disease Treatment Drugs Sales by Type (2018-2023) & (K Units)
  • Table 82. Asia Retinal Degenerative Disease Treatment Drugs Sales by Type (2024-2029) & (K Units)
  • Table 83. Asia Retinal Degenerative Disease Treatment Drugs Revenue by Type (2018-2023) & (US$ Million)
  • Table 84. Asia Retinal Degenerative Disease Treatment Drugs Revenue by Type (2024-2029) & (US$ Million)
  • Table 85. Asia Retinal Degenerative Disease Treatment Drugs Sales by Application (2018-2023) & (K Units)
  • Table 86. Asia Retinal Degenerative Disease Treatment Drugs Sales by Application (2024-2029) & (K Units)
  • Table 87. Asia Retinal Degenerative Disease Treatment Drugs Revenue by Application (2018-2023) & (US$ Million)
  • Table 88. Asia Retinal Degenerative Disease Treatment Drugs Revenue by Application (2024-2029) & (US$ Million)
  • Table 89. Asia Retinal Degenerative Disease Treatment Drugs Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
  • Table 90. Asia Retinal Degenerative Disease Treatment Drugs Revenue by Region (2018-2023) & (US$ Million)
  • Table 91. Asia Retinal Degenerative Disease Treatment Drugs Revenue by Region (2024-2029) & (US$ Million)
  • Table 92. Asia Retinal Degenerative Disease Treatment Drugs Sales by Region (2018-2023) & (K Units)
  • Table 93. Asia Retinal Degenerative Disease Treatment Drugs Sales by Region (2024-2029) & (K Units)
  • Table 94. Middle East, Africa and Latin America Retinal Degenerative Disease Treatment Drugs Sales by Type (2018-2023) & (K Units)
  • Table 95. Middle East, Africa and Latin America Retinal Degenerative Disease Treatment Drugs Sales by Type (2024-2029) & (K Units)
  • Table 96. Middle East, Africa and Latin America Retinal Degenerative Disease Treatment Drugs Revenue by Type (2018-2023) & (US$ Million)
  • Table 97. Middle East, Africa and Latin America Retinal Degenerative Disease Treatment Drugs Revenue by Type (2024-2029) & (US$ Million)
  • Table 98. Middle East, Africa and Latin America Retinal Degenerative Disease Treatment Drugs Sales by Application (2018-2023) & (K Units)
  • Table 99. Middle East, Africa and Latin America Retinal Degenerative Disease Treatment Drugs Sales by Application (2024-2029) & (K Units)
  • Table 100. Middle East, Africa and Latin America Retinal Degenerative Disease Treatment Drugs Revenue by Application (2018-2023) & (US$ Million)
  • Table 101. Middle East, Africa and Latin America Retinal Degenerative Disease Treatment Drugs Revenue by Application (2024-2029) & (US$ Million)
  • Table 102. Middle East, Africa and Latin America Retinal Degenerative Disease Treatment Drugs Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
  • Table 103. Middle East, Africa and Latin America Retinal Degenerative Disease Treatment Drugs Revenue by Country (2018-2023) & (US$ Million)
  • Table 104. Middle East, Africa and Latin America Retinal Degenerative Disease Treatment Drugs Revenue by Country (2024-2029) & (US$ Million)
  • Table 105. Middle East, Africa and Latin America Retinal Degenerative Disease Treatment Drugs Sales by Country (2018-2023) & (K Units)
  • Table 106. Middle East, Africa and Latin America Retinal Degenerative Disease Treatment Drugs Sales by Country (2024-2029) & (K Units)
  • Table 107. Regeneron Pharmaceuticals Company Information
  • Table 108. Regeneron Pharmaceuticals Description and Major Businesses
  • Table 109. Regeneron Pharmaceuticals Retinal Degenerative Disease Treatment Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
  • Table 110. Regeneron Pharmaceuticals Retinal Degenerative Disease Treatment Drugs Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 111. Regeneron Pharmaceuticals Recent Developments
  • Table 112. Bayer HealthCare Company Information
  • Table 113. Bayer HealthCare Description and Major Businesses
  • Table 114. Bayer HealthCare Retinal Degenerative Disease Treatment Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
  • Table 115. Bayer HealthCare Retinal Degenerative Disease Treatment Drugs Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 116. Bayer HealthCare Recent Developments
  • Table 117. Novartis Company Information
  • Table 118. Novartis Description and Major Businesses
  • Table 119. Novartis Retinal Degenerative Disease Treatment Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
  • Table 120. Novartis Retinal Degenerative Disease Treatment Drugs Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 121. Novartis Recent Developments
  • Table 122. Roche Company Information
  • Table 123. Roche Description and Major Businesses
  • Table 124. Roche Retinal Degenerative Disease Treatment Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
  • Table 125. Roche Retinal Degenerative Disease Treatment Drugs Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 126. Roche Recent Developments
  • Table 127. Kanghong Pharma Company Information
  • Table 128. Kanghong Pharma Description and Major Businesses
  • Table 129. Kanghong Pharma Retinal Degenerative Disease Treatment Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
  • Table 130. Kanghong Pharma Retinal Degenerative Disease Treatment Drugs Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 131. Kanghong Pharma Recent Developments
  • Table 132. Merck Company Information
  • Table 133. Merck Description and Major Businesses
  • Table 134. Merck Retinal Degenerative Disease Treatment Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
  • Table 135. Merck Retinal Degenerative Disease Treatment Drugs Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 136. Merck Recent Developments
  • Table 137. Takeda Company Information
  • Table 138. Takeda Description and Major Businesses
  • Table 139. Takeda Retinal Degenerative Disease Treatment Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
  • Table 140. Takeda Retinal Degenerative Disease Treatment Drugs Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 141. Takeda Recent Developments
  • Table 142. Valeant Pharmaceuticals International, Inc Company Information
  • Table 143. Valeant Pharmaceuticals International, Inc Description and Major Businesses
  • Table 144. Valeant Pharmaceuticals International, Inc Retinal Degenerative Disease Treatment Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
  • Table 145. Valeant Pharmaceuticals International, Inc Retinal Degenerative Disease Treatment Drugs Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 146. Valeant Pharmaceuticals International, Inc Recent Developments
  • Table 147. Oxurion(ThromboGenics) Company Information
  • Table 148. Oxurion(ThromboGenics) Description and Major Businesses
  • Table 149. Oxurion(ThromboGenics) Retinal Degenerative Disease Treatment Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
  • Table 150. Oxurion(ThromboGenics) Retinal Degenerative Disease Treatment Drugs Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 151. Oxurion(ThromboGenics) Recent Developments
  • Table 152. Santen Pharmaceutical Company Information
  • Table 153. Santen Pharmaceutical Description and Major Businesses
  • Table 154. Santen Pharmaceutical Retinal Degenerative Disease Treatment Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
  • Table 155. Santen Pharmaceutical Retinal Degenerative Disease Treatment Drugs Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 156. Santen Pharmaceutical Recent Developments
  • Table 157. jCyte, Inc. Company Information
  • Table 158. jCyte, Inc. Description and Major Businesses
  • Table 159. jCyte, Inc. Retinal Degenerative Disease Treatment Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
  • Table 160. jCyte, Inc. Retinal Degenerative Disease Treatment Drugs Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 161. jCyte, Inc. Recent Developments
  • Table 162. Kodiak Sciences Company Information
  • Table 163. Kodiak Sciences Description and Major Businesses
  • Table 164. Kodiak Sciences Retinal Degenerative Disease Treatment Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
  • Table 165. Kodiak Sciences Retinal Degenerative Disease Treatment Drugs Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 166. Kodiak Sciences Recent Developments
  • Table 167. Coherus BioSciences, Inc Company Information
  • Table 168. Coherus BioSciences, Inc Description and Major Businesses
  • Table 169. Coherus BioSciences, Inc Retinal Degenerative Disease Treatment Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
  • Table 170. Coherus BioSciences, Inc Retinal Degenerative Disease Treatment Drugs Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 171. Coherus BioSciences, Inc Recent Developments
  • Table 172. Key Raw Materials Lists
  • Table 173. Raw Materials Key Suppliers Lists
  • Table 174. Retinal Degenerative Disease Treatment Drugs Distributors List
  • Table 175. Retinal Degenerative Disease Treatment Drugs Customers List
  • Table 176. Retinal Degenerative Disease Treatment Drugs Market Trends
  • Table 177. Retinal Degenerative Disease Treatment Drugs Market Drivers
  • Table 178. Retinal Degenerative Disease Treatment Drugs Market Challenges
  • Table 179. Retinal Degenerative Disease Treatment Drugs Market Restraints
  • Table 180. Research Programs/Design for This Report
  • Table 181. Key Data Information from Secondary Sources
  • Table 182. Key Data Information from Primary Sources

List of Figures

  • Figure 1. Retinal Degenerative Disease Treatment Drugs Product Picture
  • Figure 2. Global Retinal Degenerative Disease Treatment Drugs Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
  • Figure 3. Global Retinal Degenerative Disease Treatment Drugs Market Share by Type in 2022 & 2029
  • Figure 4. Age Related Macular Degeneration (AMD) Treatment Drug Product Picture
  • Figure 5. Retinitis Pigmentosa (RP) Treatment Drug Product Picture
  • Figure 6. Global Retinal Degenerative Disease Treatment Drugs Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
  • Figure 7. Global Retinal Degenerative Disease Treatment Drugs Market Share by Application in 2022 & 2029
  • Figure 8. Hospital
  • Figure 9. Clinic
  • Figure 10. Others
  • Figure 11. Retinal Degenerative Disease Treatment Drugs Report Years Considered
  • Figure 12. Global Retinal Degenerative Disease Treatment Drugs Revenue, (US$ Million), 2018 VS 2022 VS 2029
  • Figure 13. Global Retinal Degenerative Disease Treatment Drugs Revenue 2018-2029 (US$ Million)
  • Figure 14. Global Retinal Degenerative Disease Treatment Drugs Revenue Market Share by Region in Percentage: 2022 Versus 2029
  • Figure 15. Global Retinal Degenerative Disease Treatment Drugs Revenue Market Share by Region (2018-2029)
  • Figure 16. Global Retinal Degenerative Disease Treatment Drugs Sales 2018-2029 ((K Units)
  • Figure 17. Global Retinal Degenerative Disease Treatment Drugs Sales Market Share by Region (2018-2029)
  • Figure 18. US & Canada Retinal Degenerative Disease Treatment Drugs Sales YoY (2018-2029) & (K Units)
  • Figure 19. US & Canada Retinal Degenerative Disease Treatment Drugs Revenue YoY (2018-2029) & (US$ Million)
  • Figure 20. Europe Retinal Degenerative Disease Treatment Drugs Sales YoY (2018-2029) & (K Units)
  • Figure 21. Europe Retinal Degenerative Disease Treatment Drugs Revenue YoY (2018-2029) & (US$ Million)
  • Figure 22. China Retinal Degenerative Disease Treatment Drugs Sales YoY (2018-2029) & (K Units)
  • Figure 23. China Retinal Degenerative Disease Treatment Drugs Revenue YoY (2018-2029) & (US$ Million)
  • Figure 24. Asia (excluding China) Retinal Degenerative Disease Treatment Drugs Sales YoY (2018-2029) & (K Units)
  • Figure 25. Asia (excluding China) Retinal Degenerative Disease Treatment Drugs Revenue YoY (2018-2029) & (US$ Million)
  • Figure 26. Middle East, Africa and Latin America Retinal Degenerative Disease Treatment Drugs Sales YoY (2018-2029) & (K Units)
  • Figure 27. Middle East, Africa and Latin America Retinal Degenerative Disease Treatment Drugs Revenue YoY (2018-2029) & (US$ Million)
  • Figure 28. The Retinal Degenerative Disease Treatment Drugs Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
  • Figure 29. The Top 5 and 10 Largest Manufacturers of Retinal Degenerative Disease Treatment Drugs in the World: Market Share by Retinal Degenerative Disease Treatment Drugs Revenue in 2022
  • Figure 30. Global Retinal Degenerative Disease Treatment Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
  • Figure 31. Global Retinal Degenerative Disease Treatment Drugs Sales Market Share by Type (2018-2029)
  • Figure 32. Global Retinal Degenerative Disease Treatment Drugs Revenue Market Share by Type (2018-2029)
  • Figure 33. Global Retinal Degenerative Disease Treatment Drugs Sales Market Share by Application (2018-2029)
  • Figure 34. Global Retinal Degenerative Disease Treatment Drugs Revenue Market Share by Application (2018-2029)
  • Figure 35. US & Canada Retinal Degenerative Disease Treatment Drugs Sales Market Share by Type (2018-2029)
  • Figure 36. US & Canada Retinal Degenerative Disease Treatment Drugs Revenue Market Share by Type (2018-2029)
  • Figure 37. US & Canada Retinal Degenerative Disease Treatment Drugs Sales Market Share by Application (2018-2029)
  • Figure 38. US & Canada Retinal Degenerative Disease Treatment Drugs Revenue Market Share by Application (2018-2029)
  • Figure 39. US & Canada Retinal Degenerative Disease Treatment Drugs Revenue Share by Country (2018-2029)
  • Figure 40. US & Canada Retinal Degenerative Disease Treatment Drugs Sales Share by Country (2018-2029)
  • Figure 41. U.S. Retinal Degenerative Disease Treatment Drugs Revenue (2018-2029) & (US$ Million)
  • Figure 42. Canada Retinal Degenerative Disease Treatment Drugs Revenue (2018-2029) & (US$ Million)
  • Figure 43. Europe Retinal Degenerative Disease Treatment Drugs Sales Market Share by Type (2018-2029)
  • Figure 44. Europe Retinal Degenerative Disease Treatment Drugs Revenue Market Share by Type (2018-2029)
  • Figure 45. Europe Retinal Degenerative Disease Treatment Drugs Sales Market Share by Application (2018-2029)
  • Figure 46. Europe Retinal Degenerative Disease Treatment Drugs Revenue Market Share by Application (2018-2029)
  • Figure 47. Europe Retinal Degenerative Disease Treatment Drugs Revenue Share by Country (2018-2029)
  • Figure 48. Europe Retinal Degenerative Disease Treatment Drugs Sales Share by Country (2018-2029)
  • Figure 49. Germany Retinal Degenerative Disease Treatment Drugs Revenue (2018-2029) & (US$ Million)
  • Figure 50. France Retinal Degenerative Disease Treatment Drugs Revenue (2018-2029) & (US$ Million)
  • Figure 51. U.K. Retinal Degenerative Disease Treatment Drugs Revenue (2018-2029) & (US$ Million)
  • Figure 52. Italy Retinal Degenerative Disease Treatment Drugs Revenue (2018-2029) & (US$ Million)
  • Figure 53. Russia Retinal Degenerative Disease Treatment Drugs Revenue (2018-2029) & (US$ Million)
  • Figure 54. China Retinal Degenerative Disease Treatment Drugs Sales Market Share by Type (2018-2029)
  • Figure 55. China Retinal Degenerative Disease Treatment Drugs Revenue Market Share by Type (2018-2029)
  • Figure 56. China Retinal Degenerative Disease Treatment Drugs Sales Market Share by Application (2018-2029)
  • Figure 57. China Retinal Degenerative Disease Treatment Drugs Revenue Market Share by Application (2018-2029)
  • Figure 58. Asia Retinal Degenerative Disease Treatment Drugs Sales Market Share by Type (2018-2029)
  • Figure 59. Asia Retinal Degenerative Disease Treatment Drugs Revenue Market Share by Type (2018-2029)
  • Figure 60. Asia Retinal Degenerative Disease Treatment Drugs Sales Market Share by Application (2018-2029)
  • Figure 61. Asia Retinal Degenerative Disease Treatment Drugs Revenue Market Share by Application (2018-2029)
  • Figure 62. Asia Retinal Degenerative Disease Treatment Drugs Revenue Share by Region (2018-2029)
  • Figure 63. Asia Retinal Degenerative Disease Treatment Drugs Sales Share by Region (2018-2029)
  • Figure 64. Japan Retinal Degenerative Disease Treatment Drugs Revenue (2018-2029) & (US$ Million)
  • Figure 65. South Korea Retinal Degenerative Disease Treatment Drugs Revenue (2018-2029) & (US$ Million)
  • Figure 66. China Taiwan Retinal Degenerative Disease Treatment Drugs Revenue (2018-2029) & (US$ Million)
  • Figure 67. Southeast Asia Retinal Degenerative Disease Treatment Drugs Revenue (2018-2029) & (US$ Million)
  • Figure 68. India Retinal Degenerative Disease Treatment Drugs Revenue (2018-2029) & (US$ Million)
  • Figure 69. Middle East, Africa and Latin America Retinal Degenerative Disease Treatment Drugs Sales Market Share by Type (2018-2029)
  • Figure 70. Middle East, Africa and Latin America Retinal Degenerative Disease Treatment Drugs Revenue Market Share by Type (2018-2029)
  • Figure 71. Middle East, Africa and Latin America Retinal Degenerative Disease Treatment Drugs Sales Market Share by Application (2018-2029)
  • Figure 72. Middle East, Africa and Latin America Retinal Degenerative Disease Treatment Drugs Revenue Market Share by Application (2018-2029)
  • Figure 73. Middle East, Africa and Latin America Retinal Degenerative Disease Treatment Drugs Revenue Share by Country (2018-2029)
  • Figure 74. Middle East, Africa and Latin America Retinal Degenerative Disease Treatment Drugs Sales Share by Country (2018-2029)
  • Figure 75. Brazil Retinal Degenerative Disease Treatment Drugs Revenue (2018-2029) & (US$ Million)
  • Figure 76. Mexico Retinal Degenerative Disease Treatment Drugs Revenue (2018-2029) & (US$ Million)
  • Figure 77. Turkey Retinal Degenerative Disease Treatment Drugs Revenue (2018-2029) & (US$ Million)
  • Figure 78. Israel Retinal Degenerative Disease Treatment Drugs Revenue (2018-2029) & (US$ Million)
  • Figure 79. GCC Countries Retinal Degenerative Disease Treatment Drugs Revenue (2018-2029) & (US$ Million)
  • Figure 80. Retinal Degenerative Disease Treatment Drugs Value Chain
  • Figure 81. Retinal Degenerative Disease Treatment Drugs Production Process
  • Figure 82. Channels of Distribution
  • Figure 83. Distributors Profiles
  • Figure 84. Bottom-up and Top-down Approaches for This Report
  • Figure 85. Data Triangulation
  • Figure 86. Key Executives Interviewed
目次

This research report focuses on the Retinal Degenerative Disease Treatment Drugs Market. It analyzes market size, trends and demand forecasts, as well as growth factors and challenges. The report provides market data breakdowns by type, application, company, and region, in addition to competitive landscape and key company profiles.

TABLE OF CONTENTS

1 Study Coverage

  • 1.1 Retinal Degenerative Disease Treatment Drugs Product Introduction
  • 1.2 Market by Type
    • 1.2.1 Global Retinal Degenerative Disease Treatment Drugs Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
    • 1.2.2 Age Related Macular Degeneration (AMD) Treatment Drug
    • 1.2.3 Retinitis Pigmentosa (RP) Treatment Drug
  • 1.3 Market by Application
    • 1.3.1 Global Retinal Degenerative Disease Treatment Drugs Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
    • 1.3.2 Hospital
    • 1.3.3 Clinic
    • 1.3.4 Others
  • 1.4 Assumptions and Limitations
  • 1.5 Study Objectives
  • 1.6 Years Considered

2 Executive Summary

  • 2.1 Global Retinal Degenerative Disease Treatment Drugs Sales Estimates and Forecasts 2018-2029
  • 2.2 Global Retinal Degenerative Disease Treatment Drugs Revenue by Region
    • 2.2.1 Global Retinal Degenerative Disease Treatment Drugs Revenue by Region: 2018 VS 2022 VS 2029
    • 2.2.2 Global Retinal Degenerative Disease Treatment Drugs Revenue by Region (2018-2023)
    • 2.2.3 Global Retinal Degenerative Disease Treatment Drugs Revenue by Region (2024-2029)
    • 2.2.4 Global Retinal Degenerative Disease Treatment Drugs Revenue Market Share by Region (2018-2029)
  • 2.3 Global Retinal Degenerative Disease Treatment Drugs Sales Estimates and Forecasts 2018-2029
  • 2.4 Global Retinal Degenerative Disease Treatment Drugs Sales by Region
    • 2.4.1 Global Retinal Degenerative Disease Treatment Drugs Sales by Region: 2018 VS 2022 VS 2029
    • 2.4.2 Global Retinal Degenerative Disease Treatment Drugs Sales by Region (2018-2023)
    • 2.4.3 Global Retinal Degenerative Disease Treatment Drugs Sales by Region (2024-2029)
    • 2.4.4 Global Retinal Degenerative Disease Treatment Drugs Sales Market Share by Region (2018-2029)
  • 2.5 US & Canada
  • 2.6 Europe
  • 2.7 China
  • 2.8 Asia (excluding China)
  • 2.9 Middle East, Africa and Latin America

3 Competition by Manufactures

  • 3.1 Global Retinal Degenerative Disease Treatment Drugs Sales by Manufacturers
    • 3.1.1 Global Retinal Degenerative Disease Treatment Drugs Sales by Manufacturers (2018-2023)
    • 3.1.2 Global Retinal Degenerative Disease Treatment Drugs Sales Market Share by Manufacturers (2018-2023)
    • 3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Retinal Degenerative Disease Treatment Drugs in 2022
  • 3.2 Global Retinal Degenerative Disease Treatment Drugs Revenue by Manufacturers
    • 3.2.1 Global Retinal Degenerative Disease Treatment Drugs Revenue by Manufacturers (2018-2023)
    • 3.2.2 Global Retinal Degenerative Disease Treatment Drugs Revenue Market Share by Manufacturers (2018-2023)
    • 3.2.3 Global Top 10 and Top 5 Companies by Retinal Degenerative Disease Treatment Drugs Revenue in 2022
  • 3.3 Global Key Players of Retinal Degenerative Disease Treatment Drugs, Industry Ranking, 2021 VS 2022 VS 2023
  • 3.4 Global Retinal Degenerative Disease Treatment Drugs Sales Price by Manufacturers
  • 3.5 Analysis of Competitive Landscape
    • 3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
    • 3.5.2 Global Retinal Degenerative Disease Treatment Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
  • 3.6 Global Key Manufacturers of Retinal Degenerative Disease Treatment Drugs, Manufacturing Base Distribution and Headquarters
  • 3.7 Global Key Manufacturers of Retinal Degenerative Disease Treatment Drugs, Product Offered and Application
  • 3.8 Global Key Manufacturers of Retinal Degenerative Disease Treatment Drugs, Date of Enter into This Industry
  • 3.9 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

  • 4.1 Global Retinal Degenerative Disease Treatment Drugs Sales by Type
    • 4.1.1 Global Retinal Degenerative Disease Treatment Drugs Historical Sales by Type (2018-2023)
    • 4.1.2 Global Retinal Degenerative Disease Treatment Drugs Forecasted Sales by Type (2024-2029)
    • 4.1.3 Global Retinal Degenerative Disease Treatment Drugs Sales Market Share by Type (2018-2029)
  • 4.2 Global Retinal Degenerative Disease Treatment Drugs Revenue by Type
    • 4.2.1 Global Retinal Degenerative Disease Treatment Drugs Historical Revenue by Type (2018-2023)
    • 4.2.2 Global Retinal Degenerative Disease Treatment Drugs Forecasted Revenue by Type (2024-2029)
    • 4.2.3 Global Retinal Degenerative Disease Treatment Drugs Revenue Market Share by Type (2018-2029)
  • 4.3 Global Retinal Degenerative Disease Treatment Drugs Price by Type
    • 4.3.1 Global Retinal Degenerative Disease Treatment Drugs Price by Type (2018-2023)
    • 4.3.2 Global Retinal Degenerative Disease Treatment Drugs Price Forecast by Type (2024-2029)

5 Market Size by Application

  • 5.1 Global Retinal Degenerative Disease Treatment Drugs Sales by Application
    • 5.1.1 Global Retinal Degenerative Disease Treatment Drugs Historical Sales by Application (2018-2023)
    • 5.1.2 Global Retinal Degenerative Disease Treatment Drugs Forecasted Sales by Application (2024-2029)
    • 5.1.3 Global Retinal Degenerative Disease Treatment Drugs Sales Market Share by Application (2018-2029)
  • 5.2 Global Retinal Degenerative Disease Treatment Drugs Revenue by Application
    • 5.2.1 Global Retinal Degenerative Disease Treatment Drugs Historical Revenue by Application (2018-2023)
    • 5.2.2 Global Retinal Degenerative Disease Treatment Drugs Forecasted Revenue by Application (2024-2029)
    • 5.2.3 Global Retinal Degenerative Disease Treatment Drugs Revenue Market Share by Application (2018-2029)
  • 5.3 Global Retinal Degenerative Disease Treatment Drugs Price by Application
    • 5.3.1 Global Retinal Degenerative Disease Treatment Drugs Price by Application (2018-2023)
    • 5.3.2 Global Retinal Degenerative Disease Treatment Drugs Price Forecast by Application (2024-2029)

6 US & Canada

  • 6.1 US & Canada Retinal Degenerative Disease Treatment Drugs Market Size by Type
    • 6.1.1 US & Canada Retinal Degenerative Disease Treatment Drugs Sales by Type (2018-2029)
    • 6.1.2 US & Canada Retinal Degenerative Disease Treatment Drugs Revenue by Type (2018-2029)
  • 6.2 US & Canada Retinal Degenerative Disease Treatment Drugs Market Size by Application
    • 6.2.1 US & Canada Retinal Degenerative Disease Treatment Drugs Sales by Application (2018-2029)
    • 6.2.2 US & Canada Retinal Degenerative Disease Treatment Drugs Revenue by Application (2018-2029)
  • 6.3 US & Canada Retinal Degenerative Disease Treatment Drugs Market Size by Country
    • 6.3.1 US & Canada Retinal Degenerative Disease Treatment Drugs Revenue by Country: 2018 VS 2022 VS 2029
    • 6.3.2 US & Canada Retinal Degenerative Disease Treatment Drugs Sales by Country (2018-2029)
    • 6.3.3 US & Canada Retinal Degenerative Disease Treatment Drugs Revenue by Country (2018-2029)
    • 6.3.4 US
    • 6.3.5 Canada

7 Europe

  • 7.1 Europe Retinal Degenerative Disease Treatment Drugs Market Size by Type
    • 7.1.1 Europe Retinal Degenerative Disease Treatment Drugs Sales by Type (2018-2029)
    • 7.1.2 Europe Retinal Degenerative Disease Treatment Drugs Revenue by Type (2018-2029)
  • 7.2 Europe Retinal Degenerative Disease Treatment Drugs Market Size by Application
    • 7.2.1 Europe Retinal Degenerative Disease Treatment Drugs Sales by Application (2018-2029)
    • 7.2.2 Europe Retinal Degenerative Disease Treatment Drugs Revenue by Application (2018-2029)
  • 7.3 Europe Retinal Degenerative Disease Treatment Drugs Market Size by Country
    • 7.3.1 Europe Retinal Degenerative Disease Treatment Drugs Revenue by Country: 2018 VS 2022 VS 2029
    • 7.3.2 Europe Retinal Degenerative Disease Treatment Drugs Sales by Country (2018-2029)
    • 7.3.3 Europe Retinal Degenerative Disease Treatment Drugs Revenue by Country (2018-2029)
    • 7.3.4 Germany
    • 7.3.5 France
    • 7.3.6 U.K.
    • 7.3.7 Italy
    • 7.3.8 Russia

8 China

  • 8.1 China Retinal Degenerative Disease Treatment Drugs Market Size
    • 8.1.1 China Retinal Degenerative Disease Treatment Drugs Sales (2018-2029)
    • 8.1.2 China Retinal Degenerative Disease Treatment Drugs Revenue (2018-2029)
  • 8.2 China Retinal Degenerative Disease Treatment Drugs Market Size by Application
    • 8.2.1 China Retinal Degenerative Disease Treatment Drugs Sales by Application (2018-2029)
    • 8.2.2 China Retinal Degenerative Disease Treatment Drugs Revenue by Application (2018-2029)

9 Asia (excluding China)

  • 9.1 Asia Retinal Degenerative Disease Treatment Drugs Market Size by Type
    • 9.1.1 Asia Retinal Degenerative Disease Treatment Drugs Sales by Type (2018-2029)
    • 9.1.2 Asia Retinal Degenerative Disease Treatment Drugs Revenue by Type (2018-2029)
  • 9.2 Asia Retinal Degenerative Disease Treatment Drugs Market Size by Application
    • 9.2.1 Asia Retinal Degenerative Disease Treatment Drugs Sales by Application (2018-2029)
    • 9.2.2 Asia Retinal Degenerative Disease Treatment Drugs Revenue by Application (2018-2029)
  • 9.3 Asia Retinal Degenerative Disease Treatment Drugs Sales by Region
    • 9.3.1 Asia Retinal Degenerative Disease Treatment Drugs Revenue by Region: 2018 VS 2022 VS 2029
    • 9.3.2 Asia Retinal Degenerative Disease Treatment Drugs Revenue by Region (2018-2029)
    • 9.3.3 Asia Retinal Degenerative Disease Treatment Drugs Sales by Region (2018-2029)
    • 9.3.4 Japan
    • 9.3.5 South Korea
    • 9.3.6 China Taiwan
    • 9.3.7 Southeast Asia
    • 9.3.8 India

10 Middle East, Africa and Latin America

  • 10.1 Middle East, Africa and Latin America Retinal Degenerative Disease Treatment Drugs Market Size by Type
    • 10.1.1 Middle East, Africa and Latin America Retinal Degenerative Disease Treatment Drugs Sales by Type (2018-2029)
    • 10.1.2 Middle East, Africa and Latin America Retinal Degenerative Disease Treatment Drugs Revenue by Type (2018-2029)
  • 10.2 Middle East, Africa and Latin America Retinal Degenerative Disease Treatment Drugs Market Size by Application
    • 10.2.1 Middle East, Africa and Latin America Retinal Degenerative Disease Treatment Drugs Sales by Application (2018-2029)
    • 10.2.2 Middle East, Africa and Latin America Retinal Degenerative Disease Treatment Drugs Revenue by Application (2018-2029)
  • 10.3 Middle East, Africa and Latin America Retinal Degenerative Disease Treatment Drugs Sales by Country
    • 10.3.1 Middle East, Africa and Latin America Retinal Degenerative Disease Treatment Drugs Revenue by Country: 2018 VS 2022 VS 2029
    • 10.3.2 Middle East, Africa and Latin America Retinal Degenerative Disease Treatment Drugs Revenue by Country (2018-2029)
    • 10.3.3 Middle East, Africa and Latin America Retinal Degenerative Disease Treatment Drugs Sales by Country (2018-2029)
    • 10.3.4 Brazil
    • 10.3.5 Mexico
    • 10.3.6 Turkey
    • 10.3.7 Israel
    • 10.3.8 GCC Countries

11 Company Profiles

  • 11.1 Regeneron Pharmaceuticals
    • 11.1.1 Regeneron Pharmaceuticals Company Information
    • 11.1.2 Regeneron Pharmaceuticals Overview
    • 11.1.3 Regeneron Pharmaceuticals Retinal Degenerative Disease Treatment Drugs Sales, Price, Revenue and Gross Margin (2018-2023)
    • 11.1.4 Regeneron Pharmaceuticals Retinal Degenerative Disease Treatment Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.1.5 Regeneron Pharmaceuticals Recent Developments
  • 11.2 Bayer HealthCare
    • 11.2.1 Bayer HealthCare Company Information
    • 11.2.2 Bayer HealthCare Overview
    • 11.2.3 Bayer HealthCare Retinal Degenerative Disease Treatment Drugs Sales, Price, Revenue and Gross Margin (2018-2023)
    • 11.2.4 Bayer HealthCare Retinal Degenerative Disease Treatment Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.2.5 Bayer HealthCare Recent Developments
  • 11.3 Novartis
    • 11.3.1 Novartis Company Information
    • 11.3.2 Novartis Overview
    • 11.3.3 Novartis Retinal Degenerative Disease Treatment Drugs Sales, Price, Revenue and Gross Margin (2018-2023)
    • 11.3.4 Novartis Retinal Degenerative Disease Treatment Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.3.5 Novartis Recent Developments
  • 11.4 Roche
    • 11.4.1 Roche Company Information
    • 11.4.2 Roche Overview
    • 11.4.3 Roche Retinal Degenerative Disease Treatment Drugs Sales, Price, Revenue and Gross Margin (2018-2023)
    • 11.4.4 Roche Retinal Degenerative Disease Treatment Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.4.5 Roche Recent Developments
  • 11.5 Kanghong Pharma
    • 11.5.1 Kanghong Pharma Company Information
    • 11.5.2 Kanghong Pharma Overview
    • 11.5.3 Kanghong Pharma Retinal Degenerative Disease Treatment Drugs Sales, Price, Revenue and Gross Margin (2018-2023)
    • 11.5.4 Kanghong Pharma Retinal Degenerative Disease Treatment Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.5.5 Kanghong Pharma Recent Developments
  • 11.6 Merck
    • 11.6.1 Merck Company Information
    • 11.6.2 Merck Overview
    • 11.6.3 Merck Retinal Degenerative Disease Treatment Drugs Sales, Price, Revenue and Gross Margin (2018-2023)
    • 11.6.4 Merck Retinal Degenerative Disease Treatment Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.6.5 Merck Recent Developments
  • 11.7 Takeda
    • 11.7.1 Takeda Company Information
    • 11.7.2 Takeda Overview
    • 11.7.3 Takeda Retinal Degenerative Disease Treatment Drugs Sales, Price, Revenue and Gross Margin (2018-2023)
    • 11.7.4 Takeda Retinal Degenerative Disease Treatment Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.7.5 Takeda Recent Developments
  • 11.8 Valeant Pharmaceuticals International, Inc
    • 11.8.1 Valeant Pharmaceuticals International, Inc Company Information
    • 11.8.2 Valeant Pharmaceuticals International, Inc Overview
    • 11.8.3 Valeant Pharmaceuticals International, Inc Retinal Degenerative Disease Treatment Drugs Sales, Price, Revenue and Gross Margin (2018-2023)
    • 11.8.4 Valeant Pharmaceuticals International, Inc Retinal Degenerative Disease Treatment Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.8.5 Valeant Pharmaceuticals International, Inc Recent Developments
  • 11.9 Oxurion(ThromboGenics)
    • 11.9.1 Oxurion(ThromboGenics) Company Information
    • 11.9.2 Oxurion(ThromboGenics) Overview
    • 11.9.3 Oxurion(ThromboGenics) Retinal Degenerative Disease Treatment Drugs Sales, Price, Revenue and Gross Margin (2018-2023)
    • 11.9.4 Oxurion(ThromboGenics) Retinal Degenerative Disease Treatment Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.9.5 Oxurion(ThromboGenics) Recent Developments
  • 11.10 Santen Pharmaceutical
    • 11.10.1 Santen Pharmaceutical Company Information
    • 11.10.2 Santen Pharmaceutical Overview
    • 11.10.3 Santen Pharmaceutical Retinal Degenerative Disease Treatment Drugs Sales, Price, Revenue and Gross Margin (2018-2023)
    • 11.10.4 Santen Pharmaceutical Retinal Degenerative Disease Treatment Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.10.5 Santen Pharmaceutical Recent Developments
  • 11.11 jCyte, Inc.
    • 11.11.1 jCyte, Inc. Company Information
    • 11.11.2 jCyte, Inc. Overview
    • 11.11.3 jCyte, Inc. Retinal Degenerative Disease Treatment Drugs Sales, Price, Revenue and Gross Margin (2018-2023)
    • 11.11.4 jCyte, Inc. Retinal Degenerative Disease Treatment Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.11.5 jCyte, Inc. Recent Developments
  • 11.12 Kodiak Sciences
    • 11.12.1 Kodiak Sciences Company Information
    • 11.12.2 Kodiak Sciences Overview
    • 11.12.3 Kodiak Sciences Retinal Degenerative Disease Treatment Drugs Sales, Price, Revenue and Gross Margin (2018-2023)
    • 11.12.4 Kodiak Sciences Retinal Degenerative Disease Treatment Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.12.5 Kodiak Sciences Recent Developments
  • 11.13 Coherus BioSciences, Inc
    • 11.13.1 Coherus BioSciences, Inc Company Information
    • 11.13.2 Coherus BioSciences, Inc Overview
    • 11.13.3 Coherus BioSciences, Inc Retinal Degenerative Disease Treatment Drugs Sales, Price, Revenue and Gross Margin (2018-2023)
    • 11.13.4 Coherus BioSciences, Inc Retinal Degenerative Disease Treatment Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.13.5 Coherus BioSciences, Inc Recent Developments

12 Industry Chain and Sales Channels Analysis

  • 12.1 Retinal Degenerative Disease Treatment Drugs Industry Chain Analysis
  • 12.2 Retinal Degenerative Disease Treatment Drugs Key Raw Materials
    • 12.2.1 Key Raw Materials
    • 12.2.2 Raw Materials Key Suppliers
  • 12.3 Retinal Degenerative Disease Treatment Drugs Production Mode & Process
  • 12.4 Retinal Degenerative Disease Treatment Drugs Sales and Marketing
    • 12.4.1 Retinal Degenerative Disease Treatment Drugs Sales Channels
    • 12.4.2 Retinal Degenerative Disease Treatment Drugs Distributors
  • 12.5 Retinal Degenerative Disease Treatment Drugs Customers

13 Market Dynamics

  • 13.1 Retinal Degenerative Disease Treatment Drugs Industry Trends
  • 13.2 Retinal Degenerative Disease Treatment Drugs Market Drivers
  • 13.3 Retinal Degenerative Disease Treatment Drugs Market Challenges
  • 13.4 Retinal Degenerative Disease Treatment Drugs Market Restraints

14 Key Findings in The Global Retinal Degenerative Disease Treatment Drugs Study

15 Appendix

  • 15.1 Research Methodology
    • 15.1.1 Methodology/Research Approach
    • 15.1.2 Data Source
  • 15.2 Author Details
  • 15.3 Disclaimer